John Overdeck’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
KWM
FCBT
EP
John Overdeck's XPH Position: Q2 2026 in Review
John Overdeck reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 29% in Q2 2026, selling an estimated $876K and leaving 35,751 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2844.
John Overdeck first reported a position in XPH in Q2 2024 and has held it in 4 quarters since. The position peaked at $2.74M in Q1 2026. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.
- John Overdeck held 35,751 shares of State Street SPDR S&P Pharmaceuticals ETF worth $2.37M as of Q2 2026.
- John Overdeck sold 14,949 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $876K.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2844 holding.
- John Overdeck first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2024 and has held it in 4 quarters since.
- John Overdeck's State Street SPDR S&P Pharmaceuticals ETF position peaked at $2.74M in Q1 2026.
- 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.